A role has been hypothesized for human cytomegalovirus (HCMV) in the etiology and pathogenesis of many different diseases. In vivo, HCMV has been shown to infect leukocytes, especially monocyte/macrophages and these have been proposed as a reservoir for HCMV persistence. Viral gene expression in peripheral blood monocytes is limited to the immediate early (IE) genes, whereas infiltrating monocytes have been observed to have a more complete expression of HCMV genes in patients with disseminated HCMV disease. The activation of monocytes during infiltration apparently makes these cells amenable to HCMV replication. The initiating event of this process is monocyte adhesion ot extracellular matrix (ECM) or cell substrates. Recent work has demonstrated that the degree and type of monocytic activation response is dependent on the substrate to which the monocyte initially binds making adhesion the key regulatory step in directing monocyte function. We hypothesize that HCMV infection (or IE expression) of monocytes during this early stage (0 to 8 hr after adhesion) will greatly alter normal monocyte activation and function. Furthermore, adhesion to specific matrices could, alone or with secondary signals influence viral gene induction and replication. Therefore, it is necessary to understand the involvement HCMV infection on normal monocyte function and activation, and to define the effect(s) that cell adhesion has on HCMV gene expression. This proposal is designed to address these issues with the following specific aims; (1) Define the susceptibility, expression pattern of HCMV genes and the cellular consequences of infection on monocytes under the influence of ECM or activating stimuli. Monocytes will be activation by adhesion alone (to fibronectin, collagen or endothelial cells), or in combination with chemical stimulation (PMA, LPS, or sodium butyrate) to identify conditions amenable to virus replication. (2) Determine the extent of IE1 and IE2 function in monocytes under normal and activating conditions using transfection functional and peptide mapping (structural) assays.
This aim should provide insight into why the viral IE products do not stimulate later virus gene expression and replication under most conditions. (3) Examine the changes in monocyte-mediated immune responses following HCMV infection and cell activation. Immune functions to be assayed include cytokine production, alterations in surface markers an cytoskeleton and adhesion (in infections of unadhered monocytes) to cellular substrates (endothelial cells).
These aims are designed to fully characterize the effect of HCMV on monocytes under laboratory conditions which closely model in vivo activating conditions. This will provide a comprehensive understanding of HCMV infections on cell types associated with inflammation, including abnormal cytokine expression in monocytes, and virus dissemination in humans.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA019014-21
Application #
6101880
Study Section
Project Start
1998-05-01
Project End
1999-09-29
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
21
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
DeKroon, Robert M; Gunawardena, Harsha P; Edwards, Rachel et al. (2018) Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. MBio 9:
Nicholls, Thomas J; Nadalutti, Cristina A; Motori, Elisa et al. (2018) Topoisomerase 3? Is Required for Decatenation and Segregation of Human mtDNA. Mol Cell 69:9-23.e6
El-Mallawany, Nader Kim; Kamiyango, William; Villiera, Jimmy et al. (2018) Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol :1-7
Selitsky, Sara R; Marron, David; Mose, Lisle E et al. (2018) Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. mSystems 3:
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Lyons, Danielle E; Yu, Kuan-Ping; Vander Heiden, Jason A et al. (2018) Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication. J Virol 92:
Bigi, Rachele; Landis, Justin T; An, Hyowon et al. (2018) Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 115:E11379-E11387
El-Mallawany, Nader Kim; Villiera, Jimmy; Kamiyango, William et al. (2018) Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer 13:33
Kobayashi, E; Aga, M; Kondo, S et al. (2018) C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes. mSphere 3:
Hopcraft, Sharon E; Pattenden, Samantha G; James, Lindsey I et al. (2018) Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 14:e1007267

Showing the most recent 10 out of 324 publications